How often should I rotate injection sites?

Each injection should be at least 2 cm from the last. With daily injections, a single site location should not be reused within 7 days. A simple 8-zone abdominal grid achieves this comfortably.

What is lipohypertrophy and how do I prevent it?

Lipohypertrophy is hardened, lumpy subcutaneous fat from repeated injections at the same spot. Prevention: rotate sites systematically, never inject into existing lumps, use fresh needles each time.

Can I inject in the thigh instead of the abdomen?

Yes. Outer/upper thigh has acceptable SC tissue for most peptides. Absorption may be slightly slower than abdominal sites. Avoid the inner thigh (proximity to femoral vessels) and the kneecap area.

Peptide Injection Site Rotation: Complete SC Site Map for UAE Researchers

Published 23 June 2026 · REVIVE Peptides Research Desk · 8 min read

TL;DR. Rotate every injection by at least 2 cm. Use a documented 8-zone abdominal grid plus thigh and deltoid backup zones. Never inject into existing lumps or scars. Fresh needle every time. Lipohypertrophy is preventable with discipline; once formed, it slows absorption and is hard to reverse.

Why Rotation Matters

Repeated injection at the same site causes lipohypertrophy — hardened, lumpy subcutaneous fat that:

Slows peptide absorption unpredictably
Reduces effective dose research subjects receive
Is cosmetically obvious and persistent
Increases pain at injection sites
Can house bacterial colonisation in micro-tears

Lipohypertrophy is well-documented in the diabetes/insulin literature (Blanco 2013 showed 64% prevalence in insulin users without rotation discipline). The same biology applies to peptide users.

The Abdominal Grid System

The abdomen is the most-used SC injection zone for peptide research. The recommended grid:

ABDOMINAL INJECTION GRID (3 cm clear zone around navel) ┌─────────┬─────────┐ │ 1 │ 2 │ ← upper right / upper left ├─────────┼─────────┤ │ 3 │ 4 │ ← mid right / mid left ├─────────┼─────────┤ │ (○ navel — avoid 3cm) ├─────────┼─────────┤ │ 5 │ 6 │ ← lower right / lower left ├─────────┼─────────┤ │ 7 │ 8 │ ← lowest right / lowest left └─────────┴─────────┘

With 8 zones and daily injection, each zone gets used once per week — meeting the 7-day rest interval. For twice-daily injection schedules (rare in peptide research), rotate to thigh or deltoid for the second daily dose.

Thigh Zones (Backup)

Zone	Location	Notes
Outer upper thigh	Hand's-width below hip, hand's-width above knee	Standard SC zone
Front thigh (anterior)	Same vertical band, front-facing	Easy self-access
Inner thigh	—	AVOID — femoral vessels

Deltoid Zone

The upper outer arm (deltoid muscle area) has acceptable SC tissue for thin individuals but limited capacity for repeated rotation. Useful for occasional use, not as primary site. Pinch the skin to confirm subcutaneous fat thickness — under 1 cm pinch and the needle may reach muscle (IM territory) which is fine for some peptides but not the SC route.

Pre-Injection Site Check

Visual inspection — no redness, bruising, lumps, or active healing
Touch inspection — feel for hard lumps or tenderness; skip if found
Alcohol swab — circular motion, allow to dry fully before injection
Pinch test — pinch 2–3 cm of fat to confirm SC depth

Common Mistakes UAE Researchers Make

Injecting through clothing. Never — even if rushed. Fibres can be carried into the wound.
Reusing needles "just once more". The cutting edge dulls after one use and a dull needle causes more tissue trauma than the price of a fresh needle.
Injecting cold peptide. Allow refrigerated vials to warm to room temperature for 5–10 minutes before injection — reduces sting.
Injecting into stretch marks or scars. Disrupted tissue absorbs unpredictably.
Skipping the alcohol-dry step. Wet alcohol on skin stings and can degrade peptide at the injection point.

Tracking Your Rotation

For multi-month research protocols, document site usage. Options:

A small notebook with date + zone number
A note app entry per injection
A printed grid on the fridge marked with marker

This matters more than it feels like it should. By month 3 of a tesamorelin or retatrutide protocol, memory of "which side did I use Tuesday?" becomes unreliable.

If Lipohypertrophy Develops

Stop injecting into that zone immediately
Use neighbouring zones for at least 3 months
Most lumps slowly soften and shrink over 3–12 months without injection
Some persist long-term — may require manual massage; rarely, dermatological referral for resistant cases

Researching peptides in the UAE?
REVIVE supplies insulin syringes alongside research peptide vials. Cold-chain delivery UAE-wide.
View research catalogue →

Research use only. All peptides supplied by REVIVE are labelled and sold strictly for in-vitro and research purposes — not for human consumption.

References

Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–453.
Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–1255.
Gentile S, Strollo F, Ceriello A, et al. Lipodystrophy in insulin-treated subjects and other injection-site skin reactions. Diabetes Ther. 2016;7(3):401–409.
Strauss K, De Gols H, Hannet I, et al. A pan-European epidemiologic study of insulin injection technique. Pract Diabetes Int. 2002;19:71–76.
Famulla S, Hövelmann U, Fischer A, et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action. Diabetes Care. 2016;39(9):1486–1492.